Prevalence and risk factors associated with allergic rhinitis in Mexican school children: Global Asthma Network Phase

Roberto García-Almaraz1, Nayely Reyes-Noriega2, Blanca Estela Del-Río-Navarro2

  • 1Hospital Infantil de Tamaulipas, Ciudad Victoria, Tamaulipas, Mexico.

Insights

Allergic rhinitis (AR) and rhinoconjunctivitis (ARC) are more prevalent in Mexican adolescents than children, particularly females. Key risk factors include wheezing, asthma, and eczema, with lower prevalence at higher altitudes.

Area of Science:

  • Epidemiology
  • Allergology
  • Pediatrics

Background:

  • Global Asthma Network (GAN) continues ISAAC's research into allergic diseases.
  • Significant variability in allergic rhinitis (AR) and rhinoconjunctivitis (ARC) prevalence exists globally.

Purpose of the Study:

  • To determine the prevalence of AR and ARC in Mexican children and adolescents.
  • To identify risk factors associated with AR and ARC in this population.

Main Methods:

  • Cross-sectional, multicentre survey (GAN Phase I) conducted in 14 Mexican cities (2016-2019).
  • Validated Spanish GAN Phase I questionnaires administered to 35,780 children (6-7 years) and 41,399 adolescents (13-14 years).

Main Results:

  • Higher AR prevalence in adolescents (26.2-37.5%) vs. children (17.9-24.9%), especially females.
  • Higher ARC prevalence in female adolescents (15.1%).
  • Significant risk factors: past 12-month wheezing, early-life wheezing, asthma diagnosis, eczema; inverse association with altitude.

Conclusions:

  • Largest AR epidemiological study in Mexico to date.
  • Demonstrates increased AR prevalence and identifies modifiable risk factors.
  • Findings can inform public health recommendations to reduce AR burden.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
832
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Allergic Reactions02:06

Allergic Reactions

Overview
29.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K